Marketing-authorisation holder · United States
ThromboGenics Inc.
2 medicines in 1 country, as authorisation holder.
Medicines
Every medicine in the registers under its name, current ones first.
2 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| JETREA2.5mg/ml · Injectable | Ocriplasmin | United States | Marketed | 2012 |
| Jetrea0.5mg/0.2ml (2.5mg/ml) · Injection | Ocriplasmin | United States | Withdrawn | 2012 |
Countries
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| United States | 2 | 1 | 1 | CompaniesAll medicines |
Top substances
The active substances in most of its medicines.
Names in the registers
How the registers spell it, normalised: legal forms, accents and capitals removed.
- thrombogenics